SCHEMBL9478

SCHEMBL9478

COc1cc2ncnc(Nc3ccc(F)c(F)c3)c2cc1O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 11/20 0.77
KDR P35968 8/20 0.77
RET P07949 7/20 0.77
KIF5B P33176 6/20 0.77
RIPK2 O43353 2/20 0.77
NOD1 Q9Y239 1/20 0.77
FBP1 P09467 2/20 0.66
CLK1 P49759 2/20 0.66
AURKA O14965 1/20 0.66
ERBB2 P04626 1/20 0.66
INSR P06213 1/20 0.66
PDGFRB P09619 1/20 0.66
FLT4 P35916 1/20 0.66
EPHB4 P54760 1/20 0.66
TEK Q02763 1/20 0.66
AURKB Q96GD4 1/20 0.66
BRAF P15056 3/20 0.65
RAF1 P04049 2/20 0.65
JAK3 P52333 2/20 0.63
ABCG2 Q9UNQ0 2/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14515606 0.90 KDR (0.72) EGFRKDRRETKIF5BRIPK2
SCHEMBL8383 0.90 EGFR (0.83) EGFRKDRRETKIF5BRIPK2
SCHEMBL30124192 0.90 EGFR (0.83) EGFRKDRRETKIF5BRIPK2
SCHEMBL29679736 0.90 EGFR (0.83) EGFRKDRRETKIF5BRIPK2
Hydrochloric Acid SCHEMBL28040041 0.89 EGFR (0.81) EGFRKDRRETKIF5BRIPK2
SCHEMBL14964757 0.88 EGFR (0.81) EGFRKDRRETKIF5BRIPK2
Hydrochloric Acid SCHEMBL27915151 0.88 EGFR (0.80) EGFRKDRRETKIF5BRIPK2
SCHEMBL22630829 0.88 EGFR (0.69) EGFRKDRRETKIF5BRIPK2
SCHEMBL643039 0.87 EGFR (0.84) EGFRKDRRETKIF5BRIPK2
SCHEMBL5864719 0.87 KDR (0.82) EGFRKDRRETKIF5BRIPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0823900-B1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2000-12-27 EP disclosed
US-5770599-A RECEPTOR TYROSINE KINASE INHIBITORS including 4-(3'-chloro-4'-fluoroanilino)-7-methoxy-6-(2-morpholinoethoxy)quinazoline (gefitinib) ZENECA LIMITED (GB) 1998-06-23 US disclosed
EP-0823900-A1 QUINAZOLINE DERIVATIVES ZENECA LIMITED (GB) 1998-02-18 EP disclosed
WO-1996033980-A1 QUINAZOLINE DERIVATIVES ZENECA LIMITED (GB) 1996-10-31 WO disclosed